The following abstracts represent the presentations given at IWWM-10 (NYC-2018), Session 7: Rituximab-based Therapy
Session Chair: Eva Kimby (Sweden)
KEYNOTE LECTURE: Usefulness of time-dependent Cox model with cause-specific competing risk analyses for assessing prognosis during the course of WM B. Hivert (France)
Bendamustine and Rituximab in treatment naïve patients with WM V. Leblond (France)
Long term efficacy of Rituximab in MAG positive peripheral neuropathy RIMAG study follow-up JM Leger (France)
Randomized clinical trial of BCR vs. FCR in treatment naïve WM patients R. Auer (UK)
Keynote Lecture: Is there a standard of care for treating treatment naïve WM? A. Olszewski (USA)